Home Cart Sign in  
Chemical Structure| 541502-14-1 Chemical Structure| 541502-14-1

Structure of Siltuximab
CAS No.: 541502-14-1

Chemical Structure| 541502-14-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Siltuximab is a humanized IgG1 monoclonal antibody that prevents IL-6 from binding to its receptor by binding to IL-6. Siltuximab has potential for research in multiple myeloma and Castleman disease.

Synonyms: CNTO-328

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Siltuximab

CAS No. :541502-14-1
M.W : 144.98 kDa
SMILES Code : NONE
Synonyms :
CNTO-328

Safety of Siltuximab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Siltuximab

pyroptosis

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05316116 Large Granular Lymphocyte Leuk... More >>emia Less << EARLY_PHASE1 ACTIVE_NOT_RECRUITING 2027-11-17 Moffitt Cancer Center, Tampa, ... More >>Florida, 33612, United States Less <<
NCT02641522 Type 1 Diabetes EARLY_PHASE1 COMPLETED 2017-03-16 Benaroya Research Institute, S... More >>eattle, Washington, 98101, United States Less <<
NCT04975555 Cytokine Release Syndrome|ICAN... More >>S|Lymphoma, Non-Hodgkin|Multiple Myeloma|Acute Lymphoblastic Leukemia Less << PHASE2 RECRUITING 2027-12-31 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States Less <<
NCT01309412 Multiple Myeloma PHASE1 TERMINATED 2025-12-12 Isehara, Japan|Kyoto, Japan|Na... More >>goya, Japan|Niigata, Japan|Tokyo, Japan Less <<
NCT01400503 Multicentric Castleman's Disea... More >>se Less << PHASE2 COMPLETED 2017-03-01 Little Rock, Arkansas, United ... More >>States|Tampa, Florida, United States|Lansing, Michigan, United States|Chapel Hill, North Carolina, United States|Greenville, South Carolina, United States|Houston, Texas, United States|Seattle, Washington, United States|Leuven, Belgium|Sao Paulo, Brazil|Toronto, Canada|Beijing, China|Chengdu, China|Cairo, Egypt|Montpellier, France|Tours Cedex 9, France|Vandoeuvre Les Nancy, France|Berlin, Germany|Sha Tin, Hong Kong|Ramat Gan, Israel|Seoul, Korea, Republic of|Auckland, New Zealand|Oslo, Norway|Singapore, Singapore|Madrid, Spain|Taipei, Taiwan|Manchester, United Kingdom Less <<
NCT04838860 Idiopathic Multicentric Castle... More >>man's Disease Less << PHASE2 TERMINATED 2021-04-01 Edward W. Sparrow Hospital, La... More >>nsing, Michigan, 48912, United States Less <<
NCT05697510 Acute Myeloid Leukemia (AML) PHASE1 RECRUITING 2025-06-30 CHU de Nantes, Nantes, 44093, ... More >>France Less <<
 

Historical Records

Categories